Initial outcomes data from Cleveland Clinic’s Medical Intensive Liver Unit shows significantly improved survival rates for the first 185 cirrhotic patients managed in the new facility.
Anti-TNF Therapy Increases Infection Risk in Patients with Comorbid Inflammatory Conditions and Cirrhosis
Patients with inflammatory conditions and concomitant cirrhosis who are treated with tumor necrosis factor inhibitors face heightened risk of serious infections and other complications, according to new Cleveland Clinic research.